3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Optic Nerve Glioma
1
Neoplasms, Unknown Primary
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Astrocytoma
1
Interventions
Paclitaxel
2
Radiotherapy
1
Mebendazole
1
Fluorouracil
1
Cisplatin
1
Carboplatin
1
Capecitabine
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Neoplasms, Unknown Primary
×
Mebendazole
×
Clear all
NCT03628079
2020-01-22
RepoMeb
Repos Pharma
Phase 1/2
Terminated
11 enrolled